Stone Ridge Asset Management’s Zimmer Biomet ZBH Stock Holding History

Stone Ridge Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,464	Closed	-$550K	–	1250
2018 Q4	$550K	Buy	5,464 +882	+19%	+$99.2K	0.03%	729
2018 Q3	$585K	Buy	4,582 +703	+18%	+$83.6K	0.03%	773
2018 Q2	$420K	Buy	3,879 +377	+11%	+$41K	0.02%	875
2018 Q1	$371K	Buy	3,502 +927	+36%	+$108K	0.02%	935
2017 Q4	$302K	Buy	+2,575	New	+$291K	0.02%	1059

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stone Ridge Asset Management's ZBH Position: Q1 2019 in Review

Stone Ridge Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 5,464 shares — an estimated $550K sold.

Stone Ridge Asset Management first reported a position in ZBH in Q4 2017 and held it in 5 quarters. The position peaked at $585K in Q3 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

Stone Ridge Asset Management reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
Stone Ridge Asset Management sold 5,464 Zimmer Biomet shares in Q1 2019, an estimated $550K.
Stone Ridge Asset Management first reported a position in Zimmer Biomet in Q4 2017 and held it in 5 quarters.
Stone Ridge Asset Management's Zimmer Biomet position peaked at $585K in Q3 2018.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Stone Ridge Asset Management's 13F filing for Q1 2019, filed 14 May 2019.